Company insider dossier

Dillard's, Inc. insider intelligence

DDS filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

50/100

No directional read

35/100 confidence
Exchange
NYSE
Sector
Consumer Cyclical
Industry
Department Stores
Latest evidence
27 Jul 2026

Investment committee read

No directional read

The tape contains filings, but none provide enough priced common-share evidence for a directional classification.

Evidence is contextual

Evidence in favour

  • Participation spans 24 named insiders rather than one filing source.

Decision risks

  • Most filings are awards, derivatives, unpriced common shares, or other securities and remain contextual.
Conviction50No directional read
Confidence35Thin evidence
Named insiders24participating in the tape
Controlled events0directional common-share events
Acquisition value$2.8Mnormalized amount
Disposal value$243.7Knormalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

681.17585.20489.23393.26297.29
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
612.14 USD
One-week move
+4.0%
Four-week move
+17.0%
Fair-value gap
+39.5%
Trend signal
Inactive
Relative strength
-7.8

Directional balance

Controlled event mix

0%acquisition
Acquisition events
0
Disposal events
0
Net value
$2.6M

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

2325 May
2901 Jun
008 Jun
015 Jun
022 Jun
1529 Jun
006 Jul
013 Jul
020 Jul
1527 Jul
003 Aug
010 Aug

Named participants

Insider conviction by person

BOLIN, TOM WVICE PRESIDENT500 events
JOHNSON, CHRIS B.SENIOR VICE PRESIDENT500 events
LITCHFORD, MIKEVICE PRESIDENT500 events
MUSGRAVE, BRANTCORPORATE VP STORES500 events
STOCKMAN, JAMES DVICE PRESIDENT500 events
WATTS, PHILLIP R.SENIOR VICE PRESIDENT500 events
WORLEY, DEAN L.VP/GENERAL COUNSEL & SECRETARY500 events
JAZIC, ANNEMARIEVICE PRESIDENT500 events
LUCIE, DENISE ALEXANDRAVICE PRESIDENT500 events
MAHAFFY, DENISE DILLARDDirector, SENIOR VICE PRESIDENT500 events
MATHENY, DRUEDirector, EXECUTIVE VICE PRESIDENT500 events
CONNOR, ROBERT CDirector500 events

Evidence quality

Security and transaction context

Common equity0
Equity compensation0
Options and derivatives0
Other securities96

Role architecture

Who is participating

Other executive35
Director34
Large holder16
CEO and chair8
Other or unspecified3

Transaction evidence

Auditable DDS filing ledger

Showing 91 to 96 of 96.

WORLEY, DEAN L.VP/GENERAL COUNSEL & SECRETARY
AcquisitionOther securities
77 sharesCommon Class A
$45.8KContext evidence
JAZIC, ANNEMARIEVICE PRESIDENT
AcquisitionOther securities
52 sharesCommon Class A
$30.9KContext evidence
LUCIE, DENISE ALEXANDRAVICE PRESIDENT
AcquisitionOther securities
52 sharesCommon Class A
$30.9KContext evidence
STOCKMAN, JAMES DVICE PRESIDENT
AcquisitionOther securities
26 sharesCommon Class A
$15.5KContext evidence
WORLEY, DEAN L.VP/GENERAL COUNSEL & SECRETARY
DisposalOther securities
100 sharesCommon Class A
Not reportedContext evidence
FREEMAN, JAMES IDirector
DisposalOther securities
75 sharesCommon Class A
Not reportedContext evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context